19-44676373-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001127893.3(CEACAM19):c.527G>A(p.Cys176Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000954 in 1,614,070 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001127893.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEACAM19 | NM_001127893.3 | c.527G>A | p.Cys176Tyr | missense_variant | 3/8 | ENST00000358777.10 | NP_001121365.1 | |
CEACAM19 | NM_020219.5 | c.527G>A | p.Cys176Tyr | missense_variant | 3/8 | NP_064604.2 | ||
CEACAM19 | NM_001389722.1 | c.527G>A | p.Cys176Tyr | missense_variant | 4/9 | NP_001376651.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEACAM19 | ENST00000358777.10 | c.527G>A | p.Cys176Tyr | missense_variant | 3/8 | 1 | NM_001127893.3 | ENSP00000351627 | A2 | |
CEACAM16-AS1 | ENST00000662585.1 | n.475+22711C>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000132 AC: 20AN: 152072Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000835 AC: 21AN: 251456Hom.: 0 AF XY: 0.0000957 AC XY: 13AN XY: 135900
GnomAD4 exome AF: 0.0000917 AC: 134AN: 1461880Hom.: 2 Cov.: 31 AF XY: 0.0000921 AC XY: 67AN XY: 727242
GnomAD4 genome AF: 0.000131 AC: 20AN: 152190Hom.: 0 Cov.: 31 AF XY: 0.000148 AC XY: 11AN XY: 74394
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 25, 2023 | The c.527G>A (p.C176Y) alteration is located in exon 3 (coding exon 3) of the CEACAM19 gene. This alteration results from a G to A substitution at nucleotide position 527, causing the cysteine (C) at amino acid position 176 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at